About Wuhan Hamilton Biotechnology
Wuhan Hamilton Biotechnology (Hamilton) is a research and development company of new human umbilical cord mesenchymal stem cells for repairing cell damage and the new generation of autoimmune cell therapy technology services for tumor treatment, including NK, DC-CIK, CAR-T, and CAR-NK. It is based in Wuhan, Hubei.
Missing: Wuhan Hamilton Biotechnology's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Wuhan Hamilton Biotechnology's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Wuhan Hamilton Biotechnology
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Wuhan Hamilton Biotechnology is included in 1 Expert Collection, including Regenerative Medicine.
Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).
Wuhan Hamilton Biotechnology Frequently Asked Questions (FAQ)
Where is Wuhan Hamilton Biotechnology's headquarters?
Wuhan Hamilton Biotechnology's headquarters is located at Building B6, Wuhan Institute of Biotechnology, Wuhan.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.